What is a stock summary page? Click here for an overview.
Business Description
PuriBlood Medical Co Ltd
ISIN : TW0006847007
Description
PuriBlood Medical Co Ltd is engaged in developing solutions for leukoreduction, cell separation, and anti-fouling materials. Its technology protects to supports living beings from medical devices to daily protection. The products of the company include Leukoreduction, Cell Separation, and P-tex.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2 | |||||
| Equity-to-Asset | 0.7 | |||||
| Debt-to-Equity | 0.28 | |||||
| Debt-to-EBITDA | -1.28 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 7.88 | |||||
| Beneish M-Score | -0.68 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 25.5 | |||||
| 3-Year EPS without NRI Growth Rate | -124.7 | |||||
| 3-Year Book Growth Rate | -2.7 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.37 | |||||
| 9-Day RSI | 32.52 | |||||
| 14-Day RSI | 33.21 | |||||
| 3-1 Month Momentum % | 1.1 | |||||
| 6-1 Month Momentum % | 17.44 | |||||
| 12-1 Month Momentum % | -9.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.34 | |||||
| Quick Ratio | 3.33 | |||||
| Cash Ratio | 3.05 | |||||
| Days Inventory | 99.89 | |||||
| Days Sales Outstanding | 15.21 | |||||
| Days Payable | 38.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -17.9 | |||||
| Shareholder Yield % | 0.55 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 11.34 | |||||
| Operating Margin % | -33.96 | |||||
| Net Margin % | -36.15 | |||||
| FCF Margin % | 6.99 | |||||
| ROE % | -24.31 | |||||
| ROA % | -16.94 | |||||
| ROIC % | -29.39 | |||||
| 3-Year ROIIC % | -128.44 | |||||
| ROC (Joel Greenblatt) % | -55.88 | |||||
| ROCE % | -19.59 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Owner-Earnings | 66.67 | |||||
| PS Ratio | 9.04 | |||||
| PB Ratio | 6.78 | |||||
| Price-to-Tangible-Book | 7.25 | |||||
| Price-to-Free-Cash-Flow | 129.47 | |||||
| Price-to-Operating-Cash-Flow | 86.73 | |||||
| EV-to-EBIT | -24.1 | |||||
| EV-to-EBITDA | -29.51 | |||||
| EV-to-Revenue | 8.66 | |||||
| EV-to-FCF | 126.27 | |||||
| Price-to-Net-Current-Asset-Value | 17.99 | |||||
| Price-to-Net-Cash | 49.63 | |||||
| Earnings Yield (Greenblatt) % | -4.14 | |||||
| FCF Yield % | 0.77 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PuriBlood Medical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 126.561 | ||
| EPS (TTM) (NT$) | -3.22 | ||
| Beta | 0.1 | ||
| 3-Year Sharpe Ratio | -0.46 | ||
| 3-Year Sortino Ratio | -0.7 | ||
| Volatility % | 24.54 | ||
| 14-Day RSI | 33.21 | ||
| 14-Day ATR (NT$) | 4.453036 | ||
| 20-Day SMA (NT$) | 90.05 | ||
| 12-1 Month Momentum % | -9.01 | ||
| 52-Week Range (NT$) | 70.1 - 122.5 | ||
| Shares Outstanding (Mil) | 14.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PuriBlood Medical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PuriBlood Medical Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
PuriBlood Medical Co Ltd Frequently Asked Questions
What is PuriBlood Medical Co Ltd(ROCO:6847)'s stock price today?
The current price of ROCO:6847 is NT$80.40. The 52 week high of ROCO:6847 is NT$122.50 and 52 week low is NT$70.10.
When is next earnings date of PuriBlood Medical Co Ltd(ROCO:6847)?
The next earnings date of PuriBlood Medical Co Ltd(ROCO:6847) is .
Does PuriBlood Medical Co Ltd(ROCO:6847) pay dividends? If so, how much?
PuriBlood Medical Co Ltd(ROCO:6847) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers